06 October 2015
In this week's EyewireTV, ReVision Optics submits to the FDA the fourth and final module of the company’s premarket approval application for the Raindrop near vision inlay; and Ocular Therapeutix submits a new drug application to the FDA for Dextenza (dexamethasone 0.4 mg) for the treatment of ocular pain following ophthalmic surgery. Also, future and current leaders in ophthalmology discuss the hottest topics from annual MillennialEYE Live meeting in Hollywood.
Print14 March 2024
26 February 2024
NovaMedica team wishes you a Merry Christmas and a Happy New Year!
26 December 2023
New breast cancer guidelines call for first mammogram at age 40 but stop short of annual screening
08 May 2024
WHO proposes recommendations for preventing nitrosamine contamination
07 May 2024
Batyr Berdyklychev is now head of the WHO office in Russia
07 May 2024
Russia expects more medical tourism due to the world’s first drug for ankylosing spondylitis
07 May 2024